Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription


1 Am J Kidney Dis
7 Diabetes Res Clin Pract
5 Intern Med
1 J Clin Endocrinol Metab
1 J Pediatr
8 Mult Scler
1 N Engl J Med
1 Nat Rev Neurol
1 Neurologia (Engl Ed)
2 PLoS One
1 Thyroid

    Am J Kidney Dis

  1. YU X, Chen N, Xue J, Mok CC, et al
    Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
    Am J Kidney Dis. 2022 Sep 1. pii: S0272-6386(22)00860.
    >> Share

    Diabetes Res Clin Pract

  2. ATHANASIADOU KI, Paschou SA, Stamatopoulos T, Papakonstantinou E, et al
    Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials.
    Diabetes Res Clin Pract. 2022;190:110020.
    >> Share

  3. TECCE N, Masulli M, Palmisano L, Gianfrancesco S, et al
    Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study.
    Diabetes Res Clin Pract. 2022;190:110001.
    >> Share

  4. BAECHLE C, Stahl-Pehe A, Prinz N, Meissner T, et al
    Prevalence trends of type 1 and type 2 diabetes in children and adolescents in North Rhine-Westphalia, the most populous federal state in Germany, 2002-2020.
    Diabetes Res Clin Pract. 2022;190:109995.
    >> Share

  5. POLONSKY WH, Hood KK, Levy CJ, MacLeish SA, et al
    How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod(R) 5 System.
    Diabetes Res Clin Pract. 2022;190:109998.
    >> Share

  6. BARUTTA F, Bellini S, Guarrera S, Matullo G, et al
    Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study.
    Diabetes Res Clin Pract. 2022;190:109987.
    >> Share

  7. CIARDULLO S, Perseghin G
    Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2022;190:109981.
    >> Share

  8. ABIRU N, Shoji S, Kosakai Y, Snijder R, et al
    Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis.
    Diabetes Res Clin Pract. 2022;190:109973.
    >> Share

    Intern Med

  9. YAMAMOTO H, Komatsu M, Sonehara K, Ikuyama Y, et al
    Usual Interstitial Pneumonia Pattern Interstitial Lung Disease Developed in a Patient with IgG4-related Chronic Sclerosing Sialadenitis.
    Intern Med. 2022;61:2637-2642.
    >> Share

  10. FUTAMURA M, Ozaki Y, Makino H, Tsujimoto S, et al
    A Case of Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous Leukemia.
    Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.9529.
    >> Share

  11. HARA R, Hasegawa E, Inoue N, Sekine A, et al
    Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine: A Case Report.
    Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.9410.
    >> Share

  12. SHIMODA M, Ishii H, Tanaka Y, Morimoto K, et al
    A Case of Autoimmune Pulmonary Alveolar Proteinosis with Suspected Exacerbation after Osimertinib Administration for Lung Cancer.
    Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.0256.
    >> Share

  13. SAWAMURA M, Sawa N, Ikuma D, Oba Y, et al
    Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient With Lupus Nephritis: A Case Report.
    Intern Med. 2022 Sep 6. doi: 10.2169/internalmedicine.0160.
    >> Share

    J Clin Endocrinol Metab

  14. GRACE SL, Bowden J, Walkey HC, Kaur A, et al
    Islet autoantibody level distribution in type 1 diabetes and their association with genetic and clinical characteristics.
    J Clin Endocrinol Metab. 2022 Sep 8. pii: 6693901. doi: 10.1210.
    >> Share

    J Pediatr

  15. SRINIVASAN S, Todd J
    The genetics of type 2 diabetes in youth: Where we are and the road ahead.
    J Pediatr. 2022 Jun 1. pii: S0022-3476(22)00514.
    >> Share

    Mult Scler

  16. ZARGHAMI A, van der Mei I, Hussain MA, Claflin SB, et al
    Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
    Mult Scler. 2022;28:1793-1807.
    >> Share

  17. CAPANNA M, Signori A, Sormani MP
    Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.
    Mult Scler. 2022;28:1744-1751.
    >> Share

  18. GRAF J, Ng HS, Zhu F, Zhao Y, et al
    Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits.
    Mult Scler. 2022;28:1825-1828.
    >> Share

  19. SALAMA S, Levy M
    Bright spotty lesions as an imaging marker for neuromyelitis optica spectrum disorder.
    Mult Scler. 2022;28:1663-1666.
    >> Share

  20. VAN LIEROP ZY, Noteboom S, Steenwijk MD, van Dam M, et al
    Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
    Mult Scler. 2022 Sep 3:13524585221118676. doi: 10.1177/13524585221118676.
    >> Share

  21. HARDY TA, Guo Y, Flanagan EP, Lucchinetti CF, et al
    The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions.
    Mult Scler. 2022;28:1710-1718.
    >> Share

  22. FORD CC, Cohen JA, Goodman AD, Lindsey JW, et al
    Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
    Mult Scler. 2022;28:1729-1743.
    >> Share

  23. PAUWELS A, Van Schependom J, Devolder L, Van Remoortel A, et al
    Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
    Mult Scler. 2022;28:1685-1696.
    >> Share

    N Engl J Med

  24. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

    Nat Rev Neurol

    Long-term safety of satralizumab in NMOSD.
    Nat Rev Neurol. 2022;18:510.
    >> Share

    Neurologia (Engl Ed)

  26. MARTIN-AGUILAR L, Presas-Rodriguez S, Rovira A, Capellades J, et al
    Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
    Neurologia (Engl Ed). 2022;37:557-563.
    >> Share

    PLoS One

  27. SEKIGUCHI K, Ishizuchi K, Takizawa T, Motegi H, et al
    Anemia in female patients with myasthenia gravis.
    PLoS One. 2022;17:e0273720.
    >> Share

  28. STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
    The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
    PLoS One. 2022;17:e0268421.
    >> Share


  29. SUZUKI N, Inoue K, Yoshimura R, Kinoshita A, et al
    The Mediation Role of TRAb in the Relationship between Age and Severity of Hyperthyroidism in Graves' Disease.
    Thyroid. 2022 Sep 8. doi: 10.1089/thy.2022.0252.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016